Updated 12 May 2020
medwireNews: The American College of Rheumatology (ACR) has issued clinical guidance for the care of people with rheumatic diseases in the context of the COVID-19 pandemic.
These recommendations were developed by the ACR COVID-19 Clinical Guidance Task Force, comprising 10 rheumatologists and four infectious disease specialists from North America. They provide guidance on the risk for COVID-19 among rheumatology patients, as well as direction on when to start, stop, or reduce different medications.
“All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve,” says the ACR in a press release.
The guidance is published in Arthritis & Rheumatology as a “living document,” with future updates planned as more evidence becomes available.
medwireNews is an independent medical news service provided by Springer Healthcare. © 2020 Springer Healthcare part of the Springer Nature Group
16 April 2020: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.